News

Forbes: “Clinical Trial For Brain Cancer Treatment Has Promising Results” Brain Tumor Investment Fund (BTIF) portfolio company, Alpheus Medical, was recently featured in an article on the magazine Forbes’s website. The article highlights encouraging results from an ongoing clinical trial evaluating Alpheus’s LIDU® system in patients with glioblastoma. This novel therapeutic approach – known as sonodynamic therapy – uses low-intensity ultrasound to activate a tumor-targeting […] April 2, 2026

Cordance Medical Announces an Oversubscribed $8M Seed Financing to Advance Focused Ultrasound Platform for Brain Disease Treatment Cordance Medical, a pioneer in noninvasive focused ultrasound technology for brain disease treatment, today announced an oversubscribed seed financing round led by Sonder Capital. The round surpassed its $8M target and included participation from existing and new investors, including Shanda Grab Ventures, Angel Physician’s Fund, SmartGateVC, and R42. The Sontag Foundation Innovation Fund, a subsidiary of […] November 24, 2025

Trogenix announces $95 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers -Trogenix’s breakthrough Odysseus® platform targets cancer cells to deliver precision therapies with curative “one and done” potential across multiple aggressive, treatment-resistant cancers -Financing round led by IQ Capital with participation from founding investor 4BIO Capital, returning investors Cancer Research Horizons and the National Brain Tumor Society’s Brain Tumor Investment Fund, and new investors Eli Lilly […] October 6, 2025

Diakonos Oncology Closes $20 Million Financing to Accelerate Phase 2 Glioblastoma Clinical Development Program and Expand Use of Innovative Dendritic Cell Platform for Studies in Other Indications Recent Clinical Data for Dubodencel (DOC1021) in Glioblastoma Drive Financing with Backing from Baylor College of Medicine and The Brain Tumor Investment Fund Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the closing of a $20 million private placement of Simple Agreements for Future Equity (SAFE) to […] May 30, 2025

Alpheus Medical Raises $52M in Series B Round to Advance Groundbreaking Glioblastoma Therapy Funding will support a randomized Phase 2B study of the novel sonodynamic therapy in patients with newly diagnosed glioblastoma Alpheus Medical, Inc., a private, clinical-stage oncology company pioneering sonodynamic therapy (SDT) for the treatment of solid body cancers, today announced the closing of an oversubscribed $52 million Series B financing round. The funds will support […] May 15, 2025